Travere Therapeutics, Inc. (TVTX) › EPS (Diluted)Travere Therapeutics, Inc. (TVTX) — EPS (Diluted)Annual figures by fiscal year, from SEC filings.2013: $-2.442014: $-4.432015: $3.172016: $-1.292017: $-1.542018: $-2.542019: $-3.462020: $-3.562021: $-3.012022: $-4.372023: $-1.502024: $-4.082025: $-0.29$-0.292013EPS (Diluted) (USD/shares)2025Fiscal YearEPS (Diluted)Change YoY2025$-0.29+92.9%2024$-4.08-172.0%2023$-1.50+65.7%2022$-4.37-45.2%2021$-3.01+15.4%2020$-3.56-2.9%2019$-3.46-36.2%2018$-2.54-64.9%2017$-1.54-19.4%2016$-1.29-140.7%2015$3.17+171.6%2014$-4.43-81.6%2013$-2.44—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeTotal AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share